January 04, 2012
Abbott Laboratories on Tuesday dropped five consolidated patent infringement suits against Teva Pharmaceuticals Industries Ltd. over Teva's attempts to market a generic version of Abbott's cholesterol drug Simcor.
August 16, 2011
Abbott Laboratories on Friday continued its bid to protect the market for cholesterol drug Simcor, filing another patent infringement suit in Delaware against generic-drug maker Teva Pharmaceutical Industries Ltd.